Vulvar Lesions in an 8-Year-Old Girl: Cutaneous Manifestations of Multisystem Langerhans Cell Histiocytosis

J Pediatr Adolesc Gynecol. 2018 Apr;31(2):153-155. doi: 10.1016/j.jpag.2017.09.010. Epub 2017 Oct 6.

Abstract

Background: Langerhans cell histiocytosis (LCH) is a rare localized or systemic disease characterized by proliferation of myeloid-derived dendritic cells. Vulvar lesions might be the herald symptom of LCH and might mimic other cutaneous lesions. Prognosis varies widely on the basis of the extent and spread of disease.

Case: An 8-year-old girl with a 4-month history of vulvar lesions resistant to topical steroids was referred by her pediatrician. Vulvar biopsy was diagnostic for LCH. Imaging studies revealed a left hip lesion consistent with LCH. The patient was subsequently treated for multisystem LCH with vinblastine and prednisone.

Summary and conclusion: Although rare, LCH might be diagnosed by gynecologic providers and should be included in the differential diagnosis of genital lesions. We recommend having a low threshold for performing biopsy of vulvar lesions.

Keywords: LCH; Langerhans cell histiocytosis; Vulva; Vulvar lesion.

Publication types

  • Case Reports

MeSH terms

  • Child
  • Female
  • Glucocorticoids / therapeutic use
  • Histiocytosis, Langerhans-Cell / complications*
  • Humans
  • Positron Emission Tomography Computed Tomography
  • Prednisone / therapeutic use
  • Tubulin Modulators / therapeutic use
  • Vinblastine / therapeutic use
  • Vulvar Diseases / etiology*
  • Vulvar Diseases / therapy

Substances

  • Glucocorticoids
  • Tubulin Modulators
  • Vinblastine
  • Prednisone